BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15118844)

  • 1. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide.
    Chen X; Park R; Hou Y; Khankaldyyan V; Gonzales-Gomez I; Tohme M; Bading JR; Laug WE; Conti PS
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1081-9. PubMed ID: 15118844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
    Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
    Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
    Wu Z; Li ZB; Cai W; He L; Chin FT; Li F; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1823-1831. PubMed ID: 17492285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.
    Chen X; Park R; Tohme M; Shahinian AH; Bading JR; Conti PS
    Bioconjug Chem; 2004; 15(1):41-9. PubMed ID: 14733582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide.
    Chen X; Tohme M; Park R; Hou Y; Bading JR; Conti PS
    Mol Imaging; 2004 Apr; 3(2):96-104. PubMed ID: 15296674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation.
    Chen X; Park R; Shahinian AH; Bading JR; Conti PS
    Nucl Med Biol; 2004 Jan; 31(1):11-9. PubMed ID: 14741566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4).
    Wu Z; Li ZB; Chen K; Cai W; He L; Chin FT; Li F; Chen X
    J Nucl Med; 2007 Sep; 48(9):1536-44. PubMed ID: 17704249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
    J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
    Li ZB; Chen K; Chen X
    Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
    Zhang X; Xiong Z; Wu Y; Cai W; Tseng JR; Gambhir SS; Chen X
    J Nucl Med; 2006 Jan; 47(1):113-21. PubMed ID: 16391195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
    Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X
    Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide.
    Chen X; Park R; Khankaldyyan V; Gonzales-Gomez I; Tohme M; Moats RA; Bading JR; Laug WE; Conti PS
    Mol Imaging Biol; 2006; 8(1):9-15. PubMed ID: 16315003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-labeled BBN-RGD heterodimer for prostate cancer imaging.
    Li ZB; Wu Z; Chen K; Ryu EK; Chen X
    J Nucl Med; 2008 Mar; 49(3):453-61. PubMed ID: 18287274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression.
    Cai W; Zhang X; Wu Y; Chen X
    J Nucl Med; 2006 Jul; 47(7):1172-80. PubMed ID: 16818952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An engineered knottin peptide labeled with 18F for PET imaging of integrin expression.
    Miao Z; Ren G; Liu H; Kimura RH; Jiang L; Cochran JR; Gambhir SS; Cheng Z
    Bioconjug Chem; 2009 Dec; 20(12):2342-7. PubMed ID: 19908826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice.
    Yang G; Nie P; Kong Y; Sun H; Hou G; Han J
    Tumour Biol; 2015 May; 36(5):3285-91. PubMed ID: 25501513
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.